A retrospective study evaluating real world adherence and treatment discontinuation with trifluridine/tipiracil and regorafenib for the treatment of metastatic colorectal cancer.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 20 Feb 2018

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

20 Jan 2018 Results comparing real-world adherence and compliance patterns presented at the 2018 Gastrointestinal Cancers Symposium
07 Jun 2017 New trial record
06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com